The U.S. Centers for Disease Control and Prevention reversed course Wednesday, reinstating approximately 450 employees previously laid off under the Trump administration's federal workforce reduction ...
CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...
Moderna (NASDAQ:MRNA) Stock, Option Chain Option chain shows key data for Moderna's stock options at various strike prices and expiration dates. Traders use this information to analyze potential ...
Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...
The COVID-19 pandemic brought mRNA-based vaccines to the forefront, but the breadth of applications for this technology is much wider. As of 25 June 2024, 70 trials were recruiting patients for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results